CoreFirst Bank & Trust’s Organon & Co OGN Stock Holding History

CoreFirst Bank & Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,392	Closed	-$42K	–	450
2021 Q2	$42K	Buy	+1,392	New	+$45.8K	0.03%	276

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CoreFirst Bank & Trust's OGN Position: Q3 2021 in Review

CoreFirst Bank & Trust sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 1,392 shares — an estimated $42K sold.

CoreFirst Bank & Trust first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $42K in Q2 2021. 928 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

CoreFirst Bank & Trust reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
CoreFirst Bank & Trust sold 1,392 Organon & Co shares in Q3 2021, an estimated $42K.
CoreFirst Bank & Trust first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
CoreFirst Bank & Trust's Organon & Co position peaked at $42K in Q2 2021.
928 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on CoreFirst Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.